Market Growth

Las Vegas – September 20, 2026 -- The paroxysmal nocturnal hemoglobinuria (PNH) market across the seven major markets was valued at approximately $1.5 billion in 2025 and is projected to grow at a compound annual growth rate of 7.1% through 2036, according to DelveInsight.

Regeneron's pozelimab-cemdisiran combination leads next wave of PNH therapies

Pozelimab, a fully human anti-C5 monoclonal antibody developed on Regeneron's VelocImmune platform, is expected to generate the highest revenue among emerging PNH therapies in the seven major markets. The drug is being tested in combination with Alnylam's siRNA therapy cemdisiran; Regeneron has said Phase III results in PNH are anticipated in the fourth quarter of 2026 or the first quarter of 2027.

Redwood City – – September 18, 2026 -- Vendors shipped a record volume of Access Points in the second quarter of 2026, pushing the global WLAN market to double-digit growth across every region, according to Dell'Oro Group's newly published Wireless LAN Quarterly Report.

Wi-Fi 7 captures more than half of second-quarter WLAN sales

Wi-Fi 7 equipment accounted for over 50% of the market in 2Q26, and Dell'Oro Group expects adoption of the standard to keep rising through 2028. Senior Director Siân Morgan said the first Wi-Fi 8 revenue could appear as early as next year, but that Wi-Fi 7 will remain the dominant purchase for enterprise buyers in the interim.

Hangzhou – September 16, 2026 -- ZEEKR's Shooting Brake lineup delivered over 10,000 units globally in August, marking the third consecutive month of five-figure monthly deliveries and pushing cumulative worldwide sales past 400,000 units.

ZEEKR captures roughly 70% of the global Shooting Brake market

The milestone gives ZEEKR a commanding lead in the segment, with the brand's cumulative deliveries far outpacing rival offerings combined.

The 007GT leads H1 2026 segment sales with 26,738 units delivered

ZEEKR's total Shooting Brake sales exceeded 42,000 units in the first half of 2026, surpassing the combined total of every other brand competing in the category during the same period.

Delray Beach, Fla. – – September 15, 2026 -- The global High Flow Nasal Cannula (HFNC) market is projected to grow from USD 0.94 billion in 2026 to USD 1.44 billion by 2031, a compound annual growth rate of 8.9%, according to MarketsandMarkets.

North America leads a market shifting toward recurring consumables revenue

North America held the largest regional share of the HFNC market in 2025, supported by advanced critical-care infrastructure and established manufacturers. By product, consumables and accessories outpaced systems in market share, while adults represented the largest patient-type segment. Acute respiratory failure treatment led application demand, and hospitals remained the dominant end-user category due to intensive care unit and emergency department volumes.

Carlsbad, Calif. – September 14, 2026 -- NAMM has opened registration for The 2027 NAMM Show, a five-day gathering expected to draw more than 60,000 industry professionals from 122 countries and representing $9.8 billion in buying power. The event runs January 26–30, 2027, at the Anaheim Convention Center in Anaheim, California.

Exhibition floors open for three days of product launches and business meetings

The main show floors will be open January 28–30, offering brand experiences, product demonstrations and creator engagement across the global music products sector. Education sessions, professional development programming, networking events and industry gatherings begin two days earlier, on Tuesday, January 26.